https://longevity.stanford.edu/wp-content/uploads/2017/05/new-logo2-01-300x107.png 0 0 admin https://longevity.stanford.edu/wp-content/uploads/2017/05/new-logo2-01-300x107.png admin2012-01-04 18:39:412012-01-04 18:39:411/4/2012 - Use Biomarkers in Alzheimer's Disease Clinical Trials, Says Expert Group
1/4/2012 – Use Biomarkers in Alzheimer's Disease Clinical Trials, Says Expert Group
A group of thought leaders in Alzheimer’s disease says the science is solid and the time has come for more widespread use of biomarkers in Alzheimer disease (AD) clinical trials, to speed the identification of effective disease-modifying treatments for this incurable disorder. Recommendations by the Alzheimer’s Disease Biomarker Expert Working Group, convened by the not-for-profit Alliance for Aging Research in cooperation with the Food and Drug Administration, are published this month in a special issue of Neurobiology of Aging.
Read the full article at Market Watch